Sucampo Pharmaceuticals Inc (SCMP.OQ)

SCMP.OQ on NASDAQ Stock Exchange Global Market

24 Dec 2014
Price Change (% chg)

$0.44 (+3.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SCMP.OQ


Sucampo Pharmaceuticals, Inc. is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company’s prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to... (more)


Beta: 1.71
Market Cap (Mil.): $590.29
Shares Outstanding (Mil.): 44.35
Dividend: --
Yield (%): --


  SCMP.OQ Industry Sector
P/E (TTM): 95.73 151.53 38.61
EPS (TTM): 0.14 -- --
ROI: 6.29 -0.59 18.27
ROE: 9.88 -1.72 19.14
Search Stocks

BRIEF-Takeda and Sucampo enter into global licensing agreement for Amitiza

* Takeda and Sucampo enter into global licensing agreement for Amitiza

21 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: GlobalData
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks